NDC 52268-201

SUTAB

Sodium Sulfate, Magnesium Sulfate, And Potassium Chloride

SUTAB is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Braintree Laboratories, Inc.. The primary component is Sodium Sulfate; Magnesium Sulfate Anhydrous; Potassium Chloride.

Product ID52268-201_b48ca5eb-f031-b60b-e053-2a95a90a5ee2
NDC52268-201
Product TypeHuman Prescription Drug
Proprietary NameSUTAB
Generic NameSodium Sulfate, Magnesium Sulfate, And Potassium Chloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-11-10
Marketing CategoryNDA / NDA
Application NumberNDA213135
Labeler NameBraintree Laboratories, Inc.
Substance NameSODIUM SULFATE; MAGNESIUM SULFATE ANHYDROUS; POTASSIUM CHLORIDE
Active Ingredient Strength18 g/1; g/1; g/1
Pharm ClassesCalculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 52268-201-01

2 BOTTLE, PLASTIC in 1 KIT (52268-201-01) > 12 TABLET in 1 BOTTLE, PLASTIC
Marketing Start Date2020-11-10
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [SUTAB]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SUTAB
SUTAB
88656899 not registered Live/Pending
Sebela BT Holdings, Inc.
2019-10-16
SUTAB
SUTAB
88656848 not registered Live/Pending
Sebela BT Holdings, Inc.
2019-10-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.